Online citations, reference lists, and bibliographies.
Please confirm you are human
(Sign Up for free to never see this)
← Back to Search

Heat-inducible TNF-α Gene Therapy Combined With Hyperthermia Using Magnetic Nanoparticles As A Novel Tumor-targeted Therapy

A. Ito, M. Shinkai, H. Honda, T. Kobayashi
Published 2001 · Chemistry, Medicine

Save to my Library
Download PDF
Analyze on Scholarcy
Share
Heat-induced therapeutic gene expression is highly desired for gene therapy to minimize side effects. Furthermore, if the gene expression is triggered by heat stress, combined therapeutic effects of hyperthermia and gene therapy may be possible. We combined TNF-α gene therapy driven by the stress-inducible promoter, gadd 153, with hyperthermia using magnetite cationic liposomes (MCLs). In nude mice, MCLs induced cell death throughout much of the tumor area on heating under an alternating magnetic field. This heat stress also resulted in a 3-fold increase in TNF-α gene expression driven by the gadd 153 promoter as compared with that of nonheated tumor. TNF-α gene expression was also observed in the peripheral area where the hyperthermic effect was not enough to cause cell death. The combined treatment strongly arrested tumor growth in nude mice over a 30-day period, suggesting potential for cancer treatment. Cancer Gene Therapy (2001) 8, 649–654.
This paper references
Cancer chemotherapy : experience with TNF administration in humans
DR Spriggs
10.1038/sj.gt.3300508
Pre-existing immunity to adenovirus does not prevent tumor regression following intratumoral administration of a vector expressing IL-12 but inhibits virus dissemination
JL Bramson (1997)
10.1089/HUM.1998.9.10-1409
Transgene expression in malignant glioma using a replication-defective adenoviral vector containing the Egr-1 promoter: activation by ionizing radiation or uptake of radioactive iododeoxyuridine.
Y. Manome (1998)
10.1210/ENDO.140.5.6719
Effective genetic therapy of established medullary thyroid carcinomas with murine interleukin-2: dissemination and cytotoxicity studies in a rat tumor model.
R. Zhang (1999)
10.1097/00006123-198109000-00021
Hyperthermia for Brain Tumors
M. Salcman (1981)
Activation of the gadd153 promoter by genotoxic agents: a rapid and specific response to DNA damage.
J. D. Luethy (1992)
10.1111/j.1349-7006.1998.tb00586.x
Intracellular hyperthermia for cancer using magnetite cationic liposomes: in vitro study.
M. Shinkai (1996)
Growth inhibition of glioma cells transfected with the human beta-interferon gene by liposomes coupled with a monoclonal antibody.
M. Mizuno (1990)
10.1139/O83-061
The possible role of the superoxide ion in the induction of heat-shock and specific proteins in aerobic Drosophila cells during return to normoxia after a period of anaerobiosis.
M. Ropp (1983)
10.1252/JCEJ.34.66
Preparation of Tumor-Specific Magnetoliposomes and Their Application for Hyperthermia
B. Le (2001)
10.1016/S0304-8853(98)00586-1
Intracellular hyperthermia for cancer using magnetite cationic liposomes: an in vivo study.
M. Yanase (1998)
Synergistic cytotoxic and antitumor effects of recombinant human tumor necrosis factor and hyperthermia.
N. Watanabe (1988)
Characterization of the antitumor activities of human tumor necrosis factor-alpha and the comparison with other cytokines: induction of tumor-specific immunity.
M. Palladino (1987)
10.1111/j.1349-7006.1997.tb00429.x
Intracellular Hyperthermia for Cancer Using Magnetite Cationic Liposomes: Ex vivo Study
M. Yanase (1997)
Tumor necrosis factor alpha induces apoptosis in mammary adenocarcinoma cells by an increase in intranuclear free Ca2+ concentration and DNA fragmentation.
G. Bellomo (1992)
10.3164/JCBN.11.123
Secretion of human β-interferon into the cystic fluid of glioma transfected with the interferon gene
J. Yoshida (1991)
10.3109/02656739609027686
Cisplatin, hyperthermia and radiation treatment in human cisplatin-sensitive and resistant glioma cell lines.
G. Raaphorst (1996)
10.1016/S1389-1723(01)80015-3
Bystander-killing effect and cyclic induction of TNF-alpha gene under heat-inducible promoter gadd 153.
A. Ito (2000)
10.1038/sj.cgt.7700196
mdr1 promoter-driven tumor necrosis factor-α expression for a chemotherapy-controllable combined in vivo gene therapy and chemotherapy of tumors
W. Walther (2000)
10.1016/s0021-9258(17)46254-5
Isolation and characterization of the hamster gadd153 gene. Activation of promoter activity by agents that damage DNA.
J. D. Luethy (1990)
10.1080/026567300285367
Heat-inducible vectors for use in gene therapy
E. Gerner (2000)
10.1227/00006123-198109000-00021
Hyperthermia for brain tumors: biophysical rationale.
M. Salcman (1981)
10.3191/THERMALMEDICINE.16.91
Induction of TNF-α gene expression by heat inducible promoter gadd 153
A. Ito (2000)
Cancer chemotherapy : experience with TNF administration in humans
DR Spriggs
10.1007/s002800050568
DNA damage inducible-gene expression following platinum treatment in human ovarian carcinoma cell lines
D. Delmastro (1996)
10.3191/THERMALMEDICINE.10.168
Heat Properties of Magnetoliposomes for Local Hyperthermia
Masashige Shinkai (1994)
10.3109/02656739509004952
A system for the simultaneous delivery of intraoperative radiation and ultrasound hyperthermia
H. Montes (1995)



This paper is referenced by
10.1007/978-981-10-3328-5_9
Magnetic Nanoparticles: Functionalization and Manufacturing of Pluripotent Stem Cells
M. Horie (2017)
10.1016/J.BIOMATERIALS.2003.12.046
Cell response to dextran-derivatised iron oxide nanoparticles post internalisation.
C. Berry (2004)
10.1148/RADIOL.2392042110
Magnetic targeting of magnetoliposomes to solid tumors with MR imaging monitoring in mice: feasibility.
Jean-Paul Fortin-Ripoche (2006)
10.1016/J.TECHFORE.2012.12.006
Combined biological and health effects of electromagnetic fields and other agents in the published literature
R. Kostoff (2013)
Aspectos físicos e biológicos de nanopartículas de ferritas magnéticas
V. C. P. Fontanive (2015)
10.1080/1120009X.2020.1713508
Glioblastoma multiforme: a glance at advanced therapies based on nanotechnology
V. Rezaei (2020)
10.1021/sb4000838
Heat-inducible gene expression system by applying alternating magnetic field to magnetic nanoparticles.
M. Yamaguchi (2014)
10.1016/j.mimet.2010.10.010
Inactivation of Pseudomonas aeruginosa PA01 biofilms by hyperthermia using superparamagnetic nanoparticles.
Hongsuk Park (2011)
10.1016/j.biomaterials.2008.01.038
Using thermal energy produced by irradiation of Mn-Zn ferrite magnetic nanoparticles (MZF-NPs) for heat-inducible gene expression.
Qiu-sha Tang (2008)
10.1007/978-1-61779-953-2_17
Near-infrared fluorescence labeling of iron nanoparticles and applications for cell labeling and in vivo imaging.
J. Wang (2012)
10.5075/epfl-thesis-3566
Lipid membranes for the fabrication of functional micro- and nano-structures
Gopakumar Gopalakrishnan (2006)
10.1088/1674-1056/22/2/027506
Magnetic nanoparticle-based cancer therapy
Y. Jing (2013)
10.1002/adhm.201400391
Mechanochemical stimulation of MCF7 cells with rod-shaped Fe-Au Janus particles induces cell death through paradoxical hyperactivation of ERK.
D. Kilinc (2015)
10.7150/thno.18352
Elongated Nanoparticle Aggregates in Cancer Cells for Mechanical Destruction with Low Frequency Rotating Magnetic Field
Y. Shen (2017)
10.1080/02656736.2018.1430867
Magnetic hyperthermia therapy for the treatment of glioblastoma: a review of the therapy’s history, efficacy and application in humans
Keon Mahmoudi (2018)
10.1007/978-3-319-67609-8_2
Literature Survey on Magnetic, Gold, and Core-Shell Nanoparticles
R. Manisekaran (2018)
10.2174/2211738507666190429103814
Bioresponse Inspired Nanomaterials for Targeted Drug and Gene Delivery.
Shrestha Sharma (2019)
10.1016/j.cellbi.2008.03.014
The effect of vaccination with the lysate of heat‐shocked tumor cells on nitric oxide production in BALB/c mice with fibrosarcoma tumor
Seyed Mahmoud Hashemi (2008)
10.1016/S0142-9612(02)00440-4
Intracellular uptake of anionic superparamagnetic nanoparticles as a function of their surface coating.
C. Wilhelm (2003)
10.1002/NADC.20030511207
Nanopartikel: Gesundheitsrisiko, Therapiechance?
H. Krug (2003)
10.1007/978-90-481-2567-8_7
Bionanocomposites Assembled by “From Bottom to Top” Method
A. Pomogailo (2014)
10.3390/ijms21030958
Therapeutic Efficiency of Multiple Applications of Magnetic Hyperthermia Technique in Glioblastoma Using Aminosilane Coated Iron Oxide Nanoparticles: In Vitro and In Vivo Study
Gabriel N A Rego (2020)
10.1016/J.INTIMP.2007.02.013
Evaluation of anti-tumor effects of tumor cell lysate enriched by HSP-70 against fibrosarcoma tumor in BALB/c mice.
Seyed Mahmoud Hashemi (2007)
10.1007/s11051-012-1338-y
One-pot solvothermal synthesis of Fe3O4–PEI composite and its further modification with Au nanoparticles
Yuan-feng Wang (2012)
10.1167/tvst.8.5.18
Magnetic Hyperthermia in Y79 Retinoblastoma and ARPE-19 Retinal Epithelial Cells: Tumor Selective Apoptotic Activity of Iron Oxide Nanoparticle
Hakan Demirci (2019)
10.1016/j.addr.2009.02.009
Heat-responsive gene expression for gene therapy.
W. Walther (2009)
10.1517/17425247.3.2.205
Multi-functional polymeric nanoparticles for tumour-targeted drug delivery
Lilian E van Vlerken (2006)
10.1039/c4cc03984j
Stimuli-responsive cancer therapy based on nanoparticles.
J. Yu (2014)
10.3390/cancers5041271
Strategies in Gene Therapy for Glioblastoma
Aneta Kwiatkowska (2013)
10.1201/B11516-7
Utilization of Magnetic Nanoparticles for Cancer Therapy
D. Troyer (2011)
10.1016/j.addr.2009.03.007
Magnetic nanoparticles for theragnostics.
V. Shubayev (2009)
10.1016/J.COLSURFB.2006.11.041
Preparation of anti-human cardiac troponin I immunomagnetic nanoparticles and biological activity assays.
S. Zhang (2007)
See more
Semantic Scholar Logo Some data provided by SemanticScholar